RPL22 and neoplasm: When we assessed RPL22 levels via Immunofluorescence of TNBC patient tumor and control tissues and via qPCR in 62 TNBC tissue samples, we confirmed that this RP was present at lower levels in tumor tissues (Figures 5G–I).